You just read:

Dexcom announces publication of key study in the Journal of the American Medical Association (JAMA) demonstrating the value of CGM in reducing A1C and hypoglycemia in diabetes patients on injection therapy

News provided by

DexCom, Inc.

24 Jan, 2017, 13:51 ET